Management of lipid abnormalities in patients on CAPD.
Balaskas
E V
EV
Bamihas
G I
GI
Tourkantonis
A
A
D018752:Diet, Fat-Restricted; D015525:Fatty Acids, Omega-3 / Q000627:therapeutic use; D015248:Gemfibrozil / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D050356:Lipid Metabolism; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D017035:Pravastatin / Q000627:therapeutic use
D015525:Fatty Acids, Omega-3; D000960:Hypolipidemic Agents; D017035:Pravastatin; D015248:Gemfibrozil